Profiel
Riam Shammaa is the founder of IntelliStem Technologies, Inc. where he holds the title of Chief Executive Officer since 2019.
Dr. Shammaa is also the founder of Pallianera Pharma, Inc. Dr. Shammaa's current job is as an Independent Director at Defence Therapeutics Inc since 2021.
Actieve functies van Riam Shammaa
Bedrijven | Functie | Begin |
---|---|---|
DEFENCE THERAPEUTICS INC. | Director/Board Member | 09-11-2021 |
IntelliStem Technologies, Inc.
IntelliStem Technologies, Inc. BiotechnologyHealth Technology IntelliStem Technologies, Inc. is a Canadian biotechnology company that specializes in engineering stem cells for the development of next-generation cell therapy products. The private company is based in Toronto, Canada. The company's proprietary cell platforms, including Super Sentinel Cells (SSCs) for cancer therapeutics and IntelliCells for drug discovery and target identification, are genetically engineered. IntelliStem is currently moving into human clinical trials. The company was founded by Riam Shammaa, who has been the CEO since incorporation. | Chief Executive Officer | 04-02-2019 |
Eerdere bekende functies van Riam Shammaa
Bedrijven | Functie | Einde |
---|---|---|
Pallianera Pharma, Inc. | Founder | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
DEFENCE THERAPEUTICS INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
IntelliStem Technologies, Inc.
IntelliStem Technologies, Inc. BiotechnologyHealth Technology IntelliStem Technologies, Inc. is a Canadian biotechnology company that specializes in engineering stem cells for the development of next-generation cell therapy products. The private company is based in Toronto, Canada. The company's proprietary cell platforms, including Super Sentinel Cells (SSCs) for cancer therapeutics and IntelliCells for drug discovery and target identification, are genetically engineered. IntelliStem is currently moving into human clinical trials. The company was founded by Riam Shammaa, who has been the CEO since incorporation. | Health Technology |
Pallianera Pharma, Inc. |